PHI with Enchondromatosis
How does this condition affect your private health insurance?
Enchondrosis ossificans, commonly known as enchondroma, is a benign cartilaginous tumor that develops within the medullary cavity of bones. It arises from remnants of growth plate cartilage that fail to ossify properly. While often asymptomatic and discovered incidentally on X-rays, larger lesions or those in weight-bearing bones can cause pain, swelling, or predispose to pathological fractures. Most frequently found in the small bones of the hands and feet, they can also affect long bones like the femur or humerus. Diagnosis typically involves imaging, and treatment ranges from observation to surgical curettage for symptomatic cases or those with malignant transformation concerns, which is rare but possible, particularly in syndromic forms like Ollier's disease.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months (from symptom onset to diagnosis and potential treatment)
Duration of Illness (Lifetime)
One-time event after successful removal of a solitary lesion; chronic in cases of multiple enchondromas (Ollier's, Maffucci's) requiring monitoring or repeated interventions.
Cost of Treatment (Initial)
USD 5,000 - 20,000 (includes diagnosis, imaging, and potential surgical curettage)
Cost of Treatment (Lifetime)
USD 5,000 - 30,000 (includes initial treatment, follow-up, and potential management of recurrent or new lesions in syndromic cases)
Mortality Rate
< 0.1% (extremely rare, primarily linked to surgical complications or extremely rare malignant transformation to high-grade chondrosarcoma with metastasis)
Risk of Secondary Damages
5-15% (e.g., pathological fracture, persistent pain, very rare malignant transformation to chondrosarcoma, especially in multiple enchondromatosis syndromes)
Probability of Full Recovery
> 95% (with appropriate diagnosis and, if needed, surgical removal of a solitary lesion, although recurrence is possible in some cases or in syndromic forms)
Underlying Disease Risk
5-10% (e.g., Ollier's disease or Maffucci's syndrome, characterized by multiple enchondromas and increased risk of complications)